ATE199057T1 - Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen - Google Patents

Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen

Info

Publication number
ATE199057T1
ATE199057T1 AT92907159T AT92907159T ATE199057T1 AT E199057 T1 ATE199057 T1 AT E199057T1 AT 92907159 T AT92907159 T AT 92907159T AT 92907159 T AT92907159 T AT 92907159T AT E199057 T1 ATE199057 T1 AT E199057T1
Authority
AT
Austria
Prior art keywords
diphenylbutyl
treatment
toxic substances
disorders related
piperazine
Prior art date
Application number
AT92907159T
Other languages
English (en)
Inventor
Anders Bjoerk
Erik Christensson
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE199057T1 publication Critical patent/ATE199057T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92907159T 1991-03-22 1992-03-23 Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen ATE199057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100860A SE9100860D0 (sv) 1991-03-22 1991-03-22 New use
PCT/SE1992/000182 WO1992016211A1 (en) 1991-03-22 1992-03-23 New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders

Publications (1)

Publication Number Publication Date
ATE199057T1 true ATE199057T1 (de) 2001-02-15

Family

ID=20382242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907159T ATE199057T1 (de) 1991-03-22 1992-03-23 Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen

Country Status (24)

Country Link
US (2) US5434156A (de)
EP (1) EP0538422B1 (de)
JP (1) JP3221611B2 (de)
KR (1) KR100196674B1 (de)
AT (1) ATE199057T1 (de)
AU (1) AU653797B2 (de)
BG (1) BG61829B1 (de)
BR (1) BR9204969A (de)
CA (1) CA2083505C (de)
CZ (1) CZ282222B6 (de)
DE (1) DE69231680T2 (de)
DK (1) DK0538422T3 (de)
EE (1) EE02973B1 (de)
ES (1) ES2154261T3 (de)
GR (1) GR3035805T3 (de)
HU (2) HU9203632D0 (de)
IE (1) IE920920A1 (de)
NO (1) NO301311B1 (de)
PT (1) PT100279B (de)
RO (1) RO109702B1 (de)
RU (1) RU2095062C1 (de)
SE (1) SE9100860D0 (de)
SK (1) SK279237B6 (de)
WO (1) WO1992016211A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤
US6265393B1 (en) 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
WO2002056964A1 (es) * 2001-01-17 2002-07-25 Hythiam, Inc. Empleo de flumazenilo en la elaboración de una medicación para el tratamiento de la dependencia de alcohol
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
US20050192271A1 (en) * 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
CA2436511C (en) * 2001-02-15 2009-08-04 Juan Jose Legarda Ibanez Use of flumazenil to produce a medicament for the treatment of cocaine dependency
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
WO2003066589A1 (en) 2002-02-08 2003-08-14 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
MXPA06012059A (es) * 2004-04-22 2007-01-25 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii.
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
CA2576812A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
JP2008538741A (ja) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 鬱病の治療用及び／又は予防用の医薬組成物
EP1904182A2 (de) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Verfahren zur behandlung von drogenmissbrauch mit flibanserin
JP2008540672A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 病状に起因する性的機能不全の治療方法
JP2008540673A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤誘発性性機能不全の治療方法
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
CA2626134C (en) * 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
BRPI0712039A2 (pt) * 2006-05-09 2011-12-20 Boehringer Ingelheim Int uso de flibanserina para o tratamento de distúrbios de desejo sexual pós-menopausa
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
US20090318469A1 (en) * 2006-07-14 2009-12-24 Boehringer Ingelheim International Gmbh Use of Flibanserin for the Treatment of Sexual Disorders in Females
EP2054041A2 (de) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulierungen von flibanserin und herstellungsverfahren dafür
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
IL197129A (en) * 2006-08-25 2014-08-31 Boehringer Ingelheim Int Controlled release system and method for production
CL2008002693A1 (es) * 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
ES2154261T3 (es) 2001-04-01
EE02973B1 (et) 1997-04-15
SE9100860D0 (sv) 1991-03-22
AU653797B2 (en) 1994-10-13
RO109702B1 (ro) 1995-05-30
HUT64696A (en) 1994-02-28
BG61829B1 (bg) 1998-07-31
JP3221611B2 (ja) 2001-10-22
EP0538422B1 (de) 2001-02-07
BR9204969A (pt) 1993-07-27
DE69231680T2 (de) 2001-06-07
GR3035805T3 (en) 2001-07-31
EP0538422A1 (de) 1993-04-28
KR100196674B1 (ko) 1999-06-15
SK344992A3 (en) 1995-11-08
KR930700108A (ko) 1993-03-13
RU2095062C1 (ru) 1997-11-10
CZ344992A3 (en) 1994-02-16
HU9203632D0 (en) 1993-03-29
AU1428092A (en) 1992-10-21
IE920920A1 (en) 1992-09-23
PT100279A (pt) 1993-07-30
US5434156A (en) 1995-07-18
WO1992016211A1 (en) 1992-10-01
SK279237B6 (sk) 1998-08-05
US5618817A (en) 1997-04-08
JPH05507731A (ja) 1993-11-04
NO924502L (no) 1992-11-23
CA2083505C (en) 2003-06-10
PT100279B (pt) 1999-06-30
DK0538422T3 (da) 2001-05-07
NO924502D0 (no) 1992-11-23
HU217833B (hu) 2000-04-28
DE69231680D1 (de) 2001-03-15
BG97108A (bg) 1994-03-24
CZ282222B6 (cs) 1997-06-11
CA2083505A1 (en) 1992-09-23
NO301311B1 (no) 1997-10-13

Similar Documents

Publication Publication Date Title
ATE199057T1 (de) Neue verwendung von diphenylbutyl- piperazincarboxamiden zur behandlung von störungen im zusammenhang mit der verwendung giftiger stoffen
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
KR100321319B1 (ko) 물질남용장애를치료하는방법및제약학적조성물
ATE281162T1 (de) Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose
DE69635754D1 (de) Medikamente zur verhinderung von eingriffsbedingter stenose als folge von nicht-bypass invasiver eingriffe
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
KR940003550A (ko) 노인성 치매 예방 및 치료방법
ATE245432T1 (de) Verwendung von extrakten aus ginkgo-biloba- blättern zur behandlung von schlafstörungen
ATE232085T1 (de) Behandlung von koronaren störungen durch arzneimittelabgabe im herzbeutel
ATE103491T1 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5hydroxytryptophan.
ATE249229T1 (de) Verwendung von putamen ovi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee